カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のがん放射線療法市場予測2023-2029：外照射療法、内照射療法、全身放射線療法、静脈内放射線療法、経口放射線療法、点滴放射線療法

【英語タイトル】Cancer Radiotherapy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY7400）・商品コード：MMG23LY7400
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：71
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のがん放射線療法市場規模と予測を収録しています。・世界のがん放射線療法市場：売上、2018年-2023年、2024年-2029年
・世界のがん放射線療法市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のがん放射線療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「外照射療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

がん放射線療法のグローバル主要企業は、Siemens Healthineers、 Elekta、 Accuray Incorporated、 IBA、 ViewRay Technologies、 Hitachi Ltd.、 iCAD, Inc.、 IsoRay、 Mevion Medical Systems、 Panacea Medical Technologies、 P-cure Ltd.、 ZEISS Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、がん放射線療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のがん放射線療法市場：タイプ別、2018年-2023年、2024年-2029年
世界のがん放射線療法市場：タイプ別市場シェア、2022年
・外照射療法、内照射療法、全身放射線療法、静脈内放射線療法、経口放射線療法、点滴放射線療法

世界のがん放射線療法市場：用途別、2018年-2023年、2024年-2029年
世界のがん放射線療法市場：用途別市場シェア、2022年
・病院、独立放射線治療センター

世界のがん放射線療法市場：地域・国別、2018年-2023年、2024年-2029年
世界のがん放射線療法市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるがん放射線療法のグローバル売上、2018年-2023年
・主要企業におけるがん放射線療法のグローバル売上シェア、2022年
・主要企業におけるがん放射線療法のグローバル販売量、2018年-2023年
・主要企業におけるがん放射線療法のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Siemens Healthineers、 Elekta、 Accuray Incorporated、 IBA、 ViewRay Technologies、 Hitachi Ltd.、 iCAD, Inc.、 IsoRay、 Mevion Medical Systems、 Panacea Medical Technologies、 P-cure Ltd.、 ZEISS Group

*************************************************************

・調査・分析レポートの概要
がん放射線療法市場の定義
市場セグメント
世界のがん放射線療法市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のがん放射線療法市場規模
世界のがん放射線療法市場規模：2022年 VS 2029年
世界のがん放射線療法市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのがん放射線療法の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のがん放射線療法製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：外照射療法、内照射療法、全身放射線療法、静脈内放射線療法、経口放射線療法、点滴放射線療法
がん放射線療法のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、独立放射線治療センター
がん放射線療法の用途別グローバル売上・予測

・地域別市場分析
地域別がん放射線療法市場規模 2022年と2029年
地域別がん放射線療法売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Siemens Healthineers、 Elekta、 Accuray Incorporated、 IBA、 ViewRay Technologies、 Hitachi Ltd.、 iCAD, Inc.、 IsoRay、 Mevion Medical Systems、 Panacea Medical Technologies、 P-cure Ltd.、 ZEISS Group
...

Radiotherapy is a type of ionising radiation (high energy) that destroys the cancer cells in the treated area by damaging the DNA of these cells.
This report aims to provide a comprehensive presentation of the global market for Cancer Radiotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Radiotherapy. This report contains market size and forecasts of Cancer Radiotherapy in global, including the following market information:
Global Cancer Radiotherapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Radiotherapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cancer Radiotherapy companies in 2022 (%)
The global Cancer Radiotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
External Beam Radiotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Radiotherapy include Siemens Healthineers, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Hitachi Ltd., iCAD, Inc., IsoRay and Mevion Medical Systems, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Radiotherapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Radiotherapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Radiotherapy Market Segment Percentages, by Type, 2022 (%)
External Beam Radiotherapy
Internal Beam Radiotherapy
Systemic Radiotherapy
Intravenous Radiotherapy
Oral Radiotherapy
Instillation Radiotherapy
Global Cancer Radiotherapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Radiotherapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Independent Radiotherapy Centers
Global Cancer Radiotherapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Radiotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Radiotherapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Radiotherapy revenues share in global market, 2022 (%)
Key companies Cancer Radiotherapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Radiotherapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Siemens Healthineers
Elekta
Accuray Incorporated
IBA
ViewRay Technologies
Hitachi Ltd.
iCAD, Inc.
IsoRay
Mevion Medical Systems
Panacea Medical Technologies
P-cure Ltd.
ZEISS Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Radiotherapy, market overview.
Chapter 2: Global Cancer Radiotherapy market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Radiotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Radiotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Radiotherapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cancer Radiotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Radiotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Radiotherapy Overall Market Size
2.1 Global Cancer Radiotherapy Market Size: 2022 VS 2029
2.2 Global Cancer Radiotherapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cancer Radiotherapy Sales: 2018-2029
3 Company Landscape
3.1 Top Cancer Radiotherapy Players in Global Market
3.2 Top Global Cancer Radiotherapy Companies Ranked by Revenue
3.3 Global Cancer Radiotherapy Revenue by Companies
3.4 Global Cancer Radiotherapy Sales by Companies
3.5 Global Cancer Radiotherapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cancer Radiotherapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cancer Radiotherapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Radiotherapy Players in Global Market
3.8.1 List of Global Tier 1 Cancer Radiotherapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Radiotherapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cancer Radiotherapy Market Size Markets, 2022 & 2029
4.1.2 External Beam Radiotherapy
4.1.3 Internal Beam Radiotherapy
4.1.4 Systemic Radiotherapy
4.1.5 Intravenous Radiotherapy
4.1.6 Oral Radiotherapy
4.1.7 Instillation Radiotherapy
4.2 By Type – Global Cancer Radiotherapy Revenue & Forecasts
4.2.1 By Type – Global Cancer Radiotherapy Revenue, 2018-2023
4.2.2 By Type – Global Cancer Radiotherapy Revenue, 2024-2029
4.2.3 By Type – Global Cancer Radiotherapy Revenue Market Share, 2018-2029
4.3 By Type – Global Cancer Radiotherapy Sales & Forecasts
4.3.1 By Type – Global Cancer Radiotherapy Sales, 2018-2023
4.3.2 By Type – Global Cancer Radiotherapy Sales, 2024-2029
4.3.3 By Type – Global Cancer Radiotherapy Sales Market Share, 2018-2029
4.4 By Type – Global Cancer Radiotherapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cancer Radiotherapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Independent Radiotherapy Centers
5.2 By Application – Global Cancer Radiotherapy Revenue & Forecasts
5.2.1 By Application – Global Cancer Radiotherapy Revenue, 2018-2023
5.2.2 By Application – Global Cancer Radiotherapy Revenue, 2024-2029
5.2.3 By Application – Global Cancer Radiotherapy Revenue Market Share, 2018-2029
5.3 By Application – Global Cancer Radiotherapy Sales & Forecasts
5.3.1 By Application – Global Cancer Radiotherapy Sales, 2018-2023
5.3.2 By Application – Global Cancer Radiotherapy Sales, 2024-2029
5.3.3 By Application – Global Cancer Radiotherapy Sales Market Share, 2018-2029
5.4 By Application – Global Cancer Radiotherapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cancer Radiotherapy Market Size, 2022 & 2029
6.2 By Region – Global Cancer Radiotherapy Revenue & Forecasts
6.2.1 By Region – Global Cancer Radiotherapy Revenue, 2018-2023
6.2.2 By Region – Global Cancer Radiotherapy Revenue, 2024-2029
6.2.3 By Region – Global Cancer Radiotherapy Revenue Market Share, 2018-2029
6.3 By Region – Global Cancer Radiotherapy Sales & Forecasts
6.3.1 By Region – Global Cancer Radiotherapy Sales, 2018-2023
6.3.2 By Region – Global Cancer Radiotherapy Sales, 2024-2029
6.3.3 By Region – Global Cancer Radiotherapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cancer Radiotherapy Revenue, 2018-2029
6.4.2 By Country – North America Cancer Radiotherapy Sales, 2018-2029
6.4.3 US Cancer Radiotherapy Market Size, 2018-2029
6.4.4 Canada Cancer Radiotherapy Market Size, 2018-2029
6.4.5 Mexico Cancer Radiotherapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cancer Radiotherapy Revenue, 2018-2029
6.5.2 By Country – Europe Cancer Radiotherapy Sales, 2018-2029
6.5.3 Germany Cancer Radiotherapy Market Size, 2018-2029
6.5.4 France Cancer Radiotherapy Market Size, 2018-2029
6.5.5 U.K. Cancer Radiotherapy Market Size, 2018-2029
6.5.6 Italy Cancer Radiotherapy Market Size, 2018-2029
6.5.7 Russia Cancer Radiotherapy Market Size, 2018-2029
6.5.8 Nordic Countries Cancer Radiotherapy Market Size, 2018-2029
6.5.9 Benelux Cancer Radiotherapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cancer Radiotherapy Revenue, 2018-2029
6.6.2 By Region – Asia Cancer Radiotherapy Sales, 2018-2029
6.6.3 China Cancer Radiotherapy Market Size, 2018-2029
6.6.4 Japan Cancer Radiotherapy Market Size, 2018-2029
6.6.5 South Korea Cancer Radiotherapy Market Size, 2018-2029
6.6.6 Southeast Asia Cancer Radiotherapy Market Size, 2018-2029
6.6.7 India Cancer Radiotherapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cancer Radiotherapy Revenue, 2018-2029
6.7.2 By Country – South America Cancer Radiotherapy Sales, 2018-2029
6.7.3 Brazil Cancer Radiotherapy Market Size, 2018-2029
6.7.4 Argentina Cancer Radiotherapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cancer Radiotherapy Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cancer Radiotherapy Sales, 2018-2029
6.8.3 Turkey Cancer Radiotherapy Market Size, 2018-2029
6.8.4 Israel Cancer Radiotherapy Market Size, 2018-2029
6.8.5 Saudi Arabia Cancer Radiotherapy Market Size, 2018-2029
6.8.6 UAE Cancer Radiotherapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Siemens Healthineers
7.1.1 Siemens Healthineers Company Summary
7.1.2 Siemens Healthineers Business Overview
7.1.3 Siemens Healthineers Cancer Radiotherapy Major Product Offerings
7.1.4 Siemens Healthineers Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.1.5 Siemens Healthineers Key News & Latest Developments
7.2 Elekta
7.2.1 Elekta Company Summary
7.2.2 Elekta Business Overview
7.2.3 Elekta Cancer Radiotherapy Major Product Offerings
7.2.4 Elekta Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.2.5 Elekta Key News & Latest Developments
7.3 Accuray Incorporated
7.3.1 Accuray Incorporated Company Summary
7.3.2 Accuray Incorporated Business Overview
7.3.3 Accuray Incorporated Cancer Radiotherapy Major Product Offerings
7.3.4 Accuray Incorporated Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.3.5 Accuray Incorporated Key News & Latest Developments
7.4 IBA
7.4.1 IBA Company Summary
7.4.2 IBA Business Overview
7.4.3 IBA Cancer Radiotherapy Major Product Offerings
7.4.4 IBA Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.4.5 IBA Key News & Latest Developments
7.5 ViewRay Technologies
7.5.1 ViewRay Technologies Company Summary
7.5.2 ViewRay Technologies Business Overview
7.5.3 ViewRay Technologies Cancer Radiotherapy Major Product Offerings
7.5.4 ViewRay Technologies Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.5.5 ViewRay Technologies Key News & Latest Developments
7.6 Hitachi Ltd.
7.6.1 Hitachi Ltd. Company Summary
7.6.2 Hitachi Ltd. Business Overview
7.6.3 Hitachi Ltd. Cancer Radiotherapy Major Product Offerings
7.6.4 Hitachi Ltd. Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.6.5 Hitachi Ltd. Key News & Latest Developments
7.7 iCAD, Inc.
7.7.1 iCAD, Inc. Company Summary
7.7.2 iCAD, Inc. Business Overview
7.7.3 iCAD, Inc. Cancer Radiotherapy Major Product Offerings
7.7.4 iCAD, Inc. Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.7.5 iCAD, Inc. Key News & Latest Developments
7.8 IsoRay
7.8.1 IsoRay Company Summary
7.8.2 IsoRay Business Overview
7.8.3 IsoRay Cancer Radiotherapy Major Product Offerings
7.8.4 IsoRay Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.8.5 IsoRay Key News & Latest Developments
7.9 Mevion Medical Systems
7.9.1 Mevion Medical Systems Company Summary
7.9.2 Mevion Medical Systems Business Overview
7.9.3 Mevion Medical Systems Cancer Radiotherapy Major Product Offerings
7.9.4 Mevion Medical Systems Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.9.5 Mevion Medical Systems Key News & Latest Developments
7.10 Panacea Medical Technologies
7.10.1 Panacea Medical Technologies Company Summary
7.10.2 Panacea Medical Technologies Business Overview
7.10.3 Panacea Medical Technologies Cancer Radiotherapy Major Product Offerings
7.10.4 Panacea Medical Technologies Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.10.5 Panacea Medical Technologies Key News & Latest Developments
7.11 P-cure Ltd.
7.11.1 P-cure Ltd. Company Summary
7.11.2 P-cure Ltd. Cancer Radiotherapy Business Overview
7.11.3 P-cure Ltd. Cancer Radiotherapy Major Product Offerings
7.11.4 P-cure Ltd. Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.11.5 P-cure Ltd. Key News & Latest Developments
7.12 ZEISS Group
7.12.1 ZEISS Group Company Summary
7.12.2 ZEISS Group Cancer Radiotherapy Business Overview
7.12.3 ZEISS Group Cancer Radiotherapy Major Product Offerings
7.12.4 ZEISS Group Cancer Radiotherapy Sales and Revenue in Global (2018-2023)
7.12.5 ZEISS Group Key News & Latest Developments
8 Global Cancer Radiotherapy Production Capacity, Analysis
8.1 Global Cancer Radiotherapy Production Capacity, 2018-2029
8.2 Cancer Radiotherapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Radiotherapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Radiotherapy Supply Chain Analysis
10.1 Cancer Radiotherapy Industry Value Chain
10.2 Cancer Radiotherapy Upstream Market
10.3 Cancer Radiotherapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Radiotherapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Cancer Radiotherapy in Global Market
Table 2. Top Cancer Radiotherapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cancer Radiotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cancer Radiotherapy Revenue Share by Companies, 2018-2023
Table 5. Global Cancer Radiotherapy Sales by Companies, (K Units), 2018-2023
Table 6. Global Cancer Radiotherapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cancer Radiotherapy Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Cancer Radiotherapy Product Type
Table 9. List of Global Tier 1 Cancer Radiotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Radiotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cancer Radiotherapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Cancer Radiotherapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cancer Radiotherapy Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Cancer Radiotherapy Sales (K Units), 2018-2023
Table 15. By Type - Global Cancer Radiotherapy Sales (K Units), 2024-2029
Table 16. By Application – Global Cancer Radiotherapy Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Cancer Radiotherapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cancer Radiotherapy Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Cancer Radiotherapy Sales (K Units), 2018-2023
Table 20. By Application - Global Cancer Radiotherapy Sales (K Units), 2024-2029
Table 21. By Region – Global Cancer Radiotherapy Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Cancer Radiotherapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cancer Radiotherapy Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Cancer Radiotherapy Sales (K Units), 2018-2023
Table 25. By Region - Global Cancer Radiotherapy Sales (K Units), 2024-2029
Table 26. By Country - North America Cancer Radiotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cancer Radiotherapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Cancer Radiotherapy Sales, (K Units), 2018-2023
Table 29. By Country - North America Cancer Radiotherapy Sales, (K Units), 2024-2029
Table 30. By Country - Europe Cancer Radiotherapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cancer Radiotherapy Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Cancer Radiotherapy Sales, (K Units), 2018-2023
Table 33. By Country - Europe Cancer Radiotherapy Sales, (K Units), 2024-2029
Table 34. By Region - Asia Cancer Radiotherapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cancer Radiotherapy Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Cancer Radiotherapy Sales, (K Units), 2018-2023
Table 37. By Region - Asia Cancer Radiotherapy Sales, (K Units), 2024-2029
Table 38. By Country - South America Cancer Radiotherapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cancer Radiotherapy Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Cancer Radiotherapy Sales, (K Units), 2018-2023
Table 41. By Country - South America Cancer Radiotherapy Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Cancer Radiotherapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cancer Radiotherapy Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Cancer Radiotherapy Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Cancer Radiotherapy Sales, (K Units), 2024-2029
Table 46. Siemens Healthineers Company Summary
Table 47. Siemens Healthineers Cancer Radiotherapy Product Offerings
Table 48. Siemens Healthineers Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Siemens Healthineers Key News & Latest Developments
Table 50. Elekta Company Summary
Table 51. Elekta Cancer Radiotherapy Product Offerings
Table 52. Elekta Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Elekta Key News & Latest Developments
Table 54. Accuray Incorporated Company Summary
Table 55. Accuray Incorporated Cancer Radiotherapy Product Offerings
Table 56. Accuray Incorporated Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Accuray Incorporated Key News & Latest Developments
Table 58. IBA Company Summary
Table 59. IBA Cancer Radiotherapy Product Offerings
Table 60. IBA Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. IBA Key News & Latest Developments
Table 62. ViewRay Technologies Company Summary
Table 63. ViewRay Technologies Cancer Radiotherapy Product Offerings
Table 64. ViewRay Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. ViewRay Technologies Key News & Latest Developments
Table 66. Hitachi Ltd. Company Summary
Table 67. Hitachi Ltd. Cancer Radiotherapy Product Offerings
Table 68. Hitachi Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hitachi Ltd. Key News & Latest Developments
Table 70. iCAD, Inc. Company Summary
Table 71. iCAD, Inc. Cancer Radiotherapy Product Offerings
Table 72. iCAD, Inc. Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. iCAD, Inc. Key News & Latest Developments
Table 74. IsoRay Company Summary
Table 75. IsoRay Cancer Radiotherapy Product Offerings
Table 76. IsoRay Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. IsoRay Key News & Latest Developments
Table 78. Mevion Medical Systems Company Summary
Table 79. Mevion Medical Systems Cancer Radiotherapy Product Offerings
Table 80. Mevion Medical Systems Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Mevion Medical Systems Key News & Latest Developments
Table 82. Panacea Medical Technologies Company Summary
Table 83. Panacea Medical Technologies Cancer Radiotherapy Product Offerings
Table 84. Panacea Medical Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Panacea Medical Technologies Key News & Latest Developments
Table 86. P-cure Ltd. Company Summary
Table 87. P-cure Ltd. Cancer Radiotherapy Product Offerings
Table 88. P-cure Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. P-cure Ltd. Key News & Latest Developments
Table 90. ZEISS Group Company Summary
Table 91. ZEISS Group Cancer Radiotherapy Product Offerings
Table 92. ZEISS Group Cancer Radiotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. ZEISS Group Key News & Latest Developments
Table 94. Cancer Radiotherapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Cancer Radiotherapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Cancer Radiotherapy Production by Region, 2018-2023 (K Units)
Table 97. Global Cancer Radiotherapy Production by Region, 2024-2029 (K Units)
Table 98. Cancer Radiotherapy Market Opportunities & Trends in Global Market
Table 99. Cancer Radiotherapy Market Drivers in Global Market
Table 100. Cancer Radiotherapy Market Restraints in Global Market
Table 101. Cancer Radiotherapy Raw Materials
Table 102. Cancer Radiotherapy Raw Materials Suppliers in Global Market
Table 103. Typical Cancer Radiotherapy Downstream
Table 104. Cancer Radiotherapy Downstream Clients in Global Market
Table 105. Cancer Radiotherapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cancer Radiotherapy Segment by Type in 2022
Figure 2. Cancer Radiotherapy Segment by Application in 2022
Figure 3. Global Cancer Radiotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Radiotherapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Radiotherapy Revenue, 2018-2029 (US$, Mn)
Figure 7. Cancer Radiotherapy Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Radiotherapy Revenue in 2022
Figure 9. By Type - Global Cancer Radiotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 11. By Type - Global Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 12. By Type - Global Cancer Radiotherapy Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Cancer Radiotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 15. By Application - Global Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 16. By Application - Global Cancer Radiotherapy Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Cancer Radiotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Cancer Radiotherapy Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 20. By Region - Global Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 21. By Country - North America Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 22. By Country - North America Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 23. US Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 28. Germany Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 29. France Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 37. China Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 41. India Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 43. By Country - South America Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 44. Brazil Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Cancer Radiotherapy Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Cancer Radiotherapy Sales Market Share, 2018-2029
Figure 48. Turkey Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Cancer Radiotherapy Revenue, (US$, Mn), 2018-2029
Figure 52. Global Cancer Radiotherapy Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Cancer Radiotherapy by Region, 2022 VS 2029
Figure 54. Cancer Radiotherapy Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のがん放射線療法市場予測2023-2029：外照射療法、内照射療法、全身放射線療法、静脈内放射線療法、経口放射線療法、点滴放射線療法] (コード：MMG23LY7400)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがん放射線療法市場予測2023-2029：外照射療法、内照射療法、全身放射線療法、静脈内放射線療法、経口放射線療法、点滴放射線療法]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の放射線治療装置市場予測2023-2029：体外照射放射線治療装置、体内照射放射線治療装置、全身照射放射線治療装置
  • 世界の乳がん標的療法市場予測2023-2029：ブランド医薬品、ジェネリック医薬品
  • 世界の膀胱がん標的療法市場予測2023-2029：アテゾリズマブ（テセントリク）、アベルマブ（バベンシオ）、エルダフィチニブ（バルバーサ）、その他
  • 世界のがん迅速診断検査ボックス市場予測2023-2029：遺伝子検査、腫瘍マーカー検査、タンパク質検査、その他
  • 世界の化学療法後脱毛用頭皮冷却キャップ市場予測2023-2029：クーラー付き、クーラー無し

    • ◆H&Iグローバルリサーチのお客様（例）◆